{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:57:53Z","timestamp":1765040273693,"version":"3.44.0"},"reference-count":53,"publisher":"BMJ","issue":"1","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2010,9,24]]},"published-print":{"date-parts":[[2011,1]]},"abstract":"<jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To evaluate the efficacy of pancrealipase (PEZ) compared with placebo in the reduction of postprandial irritable bowel syndrome-diarrhoea (IBS-D).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>An intention to treat, double blind, randomised, crossover trial comparing PEZ to placebo for reduction of postprandial IBS-D. Patients had to recognise at least two different triggering foods, be willing to consume six baseline \u2018trigger meals\u2019 and again blinded with PEZ and placebo. Patients then chose which drug they preferred for another 25 meals.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>Outpatient internal medicine practice clinic.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Patients<\/jats:title>\n                  <jats:p>255 patients were screened; 83 met the criteria, including 5 years of symptoms, recognised \u2018food triggers\u2019, no other identifiable cause for the symptoms, either a normal colonoscopy or barium enema while symptomatic and able to discontinue all anticholinergic medications. 69 patients were enrolled, 20 withdrew before randomisation, leaving 49 patients: 14 men, 35 women, mean age 52 years (SD 15.3). Over 60% had experienced symptoms for 11\u201330 years and 16% for more than 40 years.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Interventions<\/jats:title>\n                  <jats:p>After completing six baseline meals, patients were randomised in blocks of four to receive either identical PEZ or a placebo for another six meals, and after a washout period of time received the alternative drug.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>The primary analysis was number of patients who chose PEZ over placebo for the extended use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Overall, 30\/49 (61%) would have chosen PEZ (p=0.078), with first drug preference for PEZ at 0.002. Among the PEZ subgroup, PEZ use compared with placebo, demonstrated improvement in all symptoms (p\u22640.001) for cramping, bloating, borborygami, urge to defecate, global pain and decrease stooling with increase in stool firmness.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>PEZ was found in a small group of patients to reduce postprandial IBS-D symptoms and deserves further evaluation.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/fg.2010.002253","type":"journal-article","created":{"date-parts":[[2010,11,3]],"date-time":"2010-11-03T20:26:53Z","timestamp":1288816013000},"page":"48-56","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":11,"title":["Pilot study: a randomised, double blind, placebo controlled trial of pancrealipase for the treatment of postprandial irritable bowel syndrome-diarrhoea"],"prefix":"10.1136","volume":"2","author":[{"given":"Mary E","family":"Money","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaroslaw","family":"Walkowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Virgilio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J","family":"Talley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2010,11,3]]},"reference":[{"key":"2025090708494559000_2.1.48.1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0889-8553(21)00553-7","article-title":"Diet and the irritable bowel syndrome","volume":"20","author":"Friedman","year":"1991","journal-title":"Gastroenterol Clin North Am"},{"key":"2025090708494559000_2.1.48.2","first-page":"499","article-title":"Irritable bowel syndrome and food intolerance","volume":"238","author":"Gertner","year":"1994","journal-title":"Practitioner"},{"key":"2025090708494559000_2.1.48.3","first-page":"65","article-title":"A dietary remedy for irritable bowel syndrome","volume":"50","author":"Cerrato","year":"1987","journal-title":"RN"},{"key":"2025090708494559000_2.1.48.4","doi-asserted-by":"publisher","DOI":"10.1136\/gut.30.8.1099"},{"key":"2025090708494559000_2.1.48.5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000051878","article-title":"Food-related gastrointestinal symptoms in the irritable bowel syndrome","volume":"63","author":"Simr\u00e9n","year":"2001","journal-title":"Digestion"},{"key":"2025090708494559000_2.1.48.6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02463.x"},{"key":"2025090708494559000_2.1.48.7","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-005-0016-y"},{"key":"2025090708494559000_2.1.48.8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01305.x"},{"key":"2025090708494559000_2.1.48.9","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/01.mog.0000208462.92136.02","article-title":"Diet and irritable bowel syndrome","volume":"22","author":"Alpers","year":"2006","journal-title":"Curr Opin Gastroenterol"},{"key":"2025090708494559000_2.1.48.10","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/00004836-200207001-00009","article-title":"Diet in the irritable bowel syndrome","volume":"35","author":"Floch","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"2025090708494559000_2.1.48.11","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2001.00951.x"},{"key":"2025090708494559000_2.1.48.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.058"},{"key":"2025090708494559000_2.1.48.13","first-page":"551","article-title":"Disaccharidase activities in dyspeptic children: biochemical and molecular investigations of maltase-glucoamylase activity","volume":"35","author":"Karnsakul","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025090708494559000_2.1.48.14","first-page":"23","article-title":"Disaccharidase deficiency in health and disease","volume":"116","author":"Herber","year":"1972","journal-title":"Calif Med"},{"key":"2025090708494559000_2.1.48.15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/ajcn\/22.2.181","article-title":"Disaccharidase deficiency","volume":"22","author":"Bayless","year":"1969","journal-title":"Am J Clin Nutr"},{"key":"2025090708494559000_2.1.48.16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/ajcn\/59.3.735S","article-title":"The clinical significance of disaccharide maldigestion","volume":"59","author":"Gudmand-H\u00f8yer","year":"1994","journal-title":"Am J Clin Nutr"},{"key":"2025090708494559000_2.1.48.17","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.01966.x"},{"key":"2025090708494559000_2.1.48.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2004.04.008"},{"key":"2025090708494559000_2.1.48.19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000089777","article-title":"Pharmacological treatment of the irritable bowel syndrome and other functional bowel disorders","volume":"73","author":"Mearin","year":"2006","journal-title":"Digestion"},{"key":"2025090708494559000_2.1.48.20","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s11938-006-0013-8","article-title":"Current gut-directed therapies for irritable bowel syndrome","volume":"9","author":"Chang","year":"2006","journal-title":"Curr Treat Options Gastroenterol"},{"key":"2025090708494559000_2.1.48.21","first-page":"487","article-title":"Establishing evidence for Chinese medicine: a case example of irritable bowel syndrome","volume":"64","author":"Bensoussan","year":"2001","journal-title":"Zhonghua Yi Xue Za Zhi (Taipei)"},{"key":"2025090708494559000_2.1.48.22","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.18.1585"},{"key":"2025090708494559000_2.1.48.23","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3109\/00365529509089786","article-title":"Oral cromolyn sodium in comparison with elimination diet in the irritable bowel syndrome, diarrheic type. Multicenter study of 428 patients","volume":"30","author":"Stefanini","year":"1995","journal-title":"Scand J Gastroenterol"},{"key":"2025090708494559000_2.1.48.24","first-page":"55","article-title":"Oral disodium cromoglycate treatment on irritable bowel syndrome: an open study on 101 subjects with diarrheic type","volume":"87","author":"Stefanini","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"2025090708494559000_2.1.48.25","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01312.x"},{"key":"2025090708494559000_2.1.48.26","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.70.3.725"},{"key":"2025090708494559000_2.1.48.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.02244.x"},{"key":"2025090708494559000_2.1.48.28","doi-asserted-by":"publisher","DOI":"10.1136\/gut.17.4.295"},{"key":"2025090708494559000_2.1.48.29","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/0016-5085(80)90776-3","article-title":"Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis","volume":"78","author":"Boyle","year":"1980","journal-title":"Gastroenterology"},{"key":"2025090708494559000_2.1.48.30","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0016-5085(86)80023-3","article-title":"Bile salt malabsorption in pancreatic insufficiency secondary to alcoholic pancreatitis","volume":"91","author":"Dutta","year":"1986","journal-title":"Gastroenterology"},{"key":"2025090708494559000_2.1.48.31","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1046\/j.1365-2036.2001.01070.x","article-title":"Efficacy of oral pancreatic enzyme therapy for the treatment of fat malabsorption in HIV-infected patients","volume":"15","author":"Carroccio","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090708494559000_2.1.48.32","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026675012864"},{"key":"2025090708494559000_2.1.48.33","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/MPA.0b013e31817c1b36","article-title":"Treatment of irritable bowel syndrome-diarrhea with pancrealipase or colesevelam and association with steatorrhea","volume":"38","author":"Money","year":"2009","journal-title":"Pancreas"},{"key":"2025090708494559000_2.1.48.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.09.032"},{"key":"2025090708494559000_2.1.48.35","doi-asserted-by":"publisher","DOI":"10.3945\/jn.108.098434"},{"key":"2025090708494559000_2.1.48.36","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/jn\/137.7.1725","article-title":"Contribution of mucosal maltase-glucoamylase activities to mouse small intestinal starch alpha-glucogenesis","volume":"137","author":"Quezada-Calvillo","year":"2007","journal-title":"J Nutr"},{"key":"2025090708494559000_2.1.48.37","doi-asserted-by":"publisher","DOI":"10.1136\/gut.45.2008.ii43"},{"key":"2025090708494559000_2.1.48.38","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1097\/00004836-200207001-00007","article-title":"Clinical assessment of irritable bowel syndrome","volume":"35","author":"Lembo","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"2025090708494559000_2.1.48.39","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018831127942"},{"key":"2025090708494559000_2.1.48.40","first-page":"246","article-title":"Antikorper gegen Gliadin und gegen Endomusium zur Diagnose der Gluten-sensitiven Enteropathie","volume":"17","author":"Schlumberger","year":"1993","journal-title":"J Lab Med"},{"key":"2025090708494559000_2.1.48.41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1984.tb06601.x"},{"key":"2025090708494559000_2.1.48.42","first-page":"1126","article-title":"An enzymatic method using 1,2 diglyceride for pancreatic lipase in serum","volume":"35","author":"Imamura","year":"1989","journal-title":"Clin Chem"},{"key":"2025090708494559000_2.1.48.43","first-page":"427","article-title":"Pankreatische Elastase-1: Parameter fur die chronische und akute pankreatitis","volume":"16","author":"Scheefers-Borchel","year":"1992","journal-title":"Lab Med"},{"key":"2025090708494559000_2.1.48.44","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1016\/S0002-9343(99)00276-4","article-title":"Diagnostic criteria for the irritable bowel syndrome","volume":"107","author":"Hammer","year":"1999","journal-title":"Am J Med"},{"key":"2025090708494559000_2.1.48.45","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2009.04087.x"},{"key":"2025090708494559000_2.1.48.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2008.02.060"},{"key":"2025090708494559000_2.1.48.47","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2009.01442.x"},{"key":"2025090708494559000_2.1.48.48","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-009-1041-8"},{"key":"2025090708494559000_2.1.48.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2009.10.009"},{"key":"2025090708494559000_2.1.48.50","doi-asserted-by":"publisher","DOI":"10.1021\/jf0712503"},{"key":"2025090708494559000_2.1.48.51","doi-asserted-by":"crossref","first-page":"11463","DOI":"10.1021\/jf903083h","article-title":"Comparative evaluation of quercetin, isoquercetin and rutin as inhibitors of alpha-glucosidase","volume":"57","author":"Li","year":"2009","journal-title":"J Agric Food Chem"},{"key":"2025090708494559000_2.1.48.52","doi-asserted-by":"publisher","DOI":"10.3177\/jnsv.53.267"},{"key":"2025090708494559000_2.1.48.53","doi-asserted-by":"publisher","DOI":"10.1021\/jf8014365"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/fg.2010.002253","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T15:49:59Z","timestamp":1757260199000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/fg.2010.002253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,3]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,12,22]]},"published-print":{"date-parts":[[2011,1]]}},"alternative-id":["10.1136\/fg.2010.002253"],"URL":"https:\/\/doi.org\/10.1136\/fg.2010.002253","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"type":"print","value":"2041-4137"},{"type":"electronic","value":"2041-4145"}],"subject":[],"published":{"date-parts":[[2010,11,3]]}}}